LSI DTCs 2007 - Graduate Academy for tissue engineering and regenerative medicine

LSI DTC 2007 - 组织工程和再生医学研究生院

• 批准号: EP/F500513/1
• 负责人: John Fisher
• 金额: $ 901.3万
• 依托单位: University of Leeds
• 依托单位国家: 英国
• 项目类别: Training Grant
• 财政年份: 2008
• 资助国家: 英国
• 起止时间: 2008 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=EP%2FF500513%2F1
• 关键词: LSI; DTCs; 2007; Graduate; Academy

Definition: A rapidly developing area at the interfaces of engineering/physical sciences, life sciences and medicine. Includes:- cell therapies (including stem cells), three dimensional cell/ matrix constructs, bioactive scaffolds, regenerative devices, in vitro tissue models for drug discovery and pre-clinical research.Social and economic needs include:Increased longevity of the ageing population with expectations of an active lifestyle and government requirements for a longer working life.Need to reduce healthcare costs, shorten hospital stays and achieve more rapid rehabilitationAn emergent disruptive industrial sector at the interface between pharmaceutical and medical devicesRequirement for relevant laboratory biological systems for screening and selection of drugs at theearly development stage, coupled with Reduction, Refinement, Replacement of in vivo testing. Translational barriers and industry needs: The tissue engineering/ regenerative medicine industry needs an increase in the number of trained multidisciplinary personnel to translate basic research, deliver new product developments, enhance manufacturing and processing capacity, to develop preclinical test methodologies and to develop standards and work within a dynamic regulatory environment. Evidence from N8 industry workshop on regenerative medicine.Academic needs: A rapidly emerging internationally competitive interdisciplinary area requiring new blood ---------------------

定义：在工程/物理科学，生命科学和医学的接口快速发展的领域。包括：-细胞疗法（包括干细胞）、三维细胞/基质构建体、生物活性支架、再生装置、用于药物发现和临床前研究的体外组织模型。随着人们对积极的生活方式的期望和政府对更长工作寿命的要求，老龄化人口的寿命延长。需要降低医疗成本，缩短住院时间，实现更快的康复。在制药和医疗器械之间的接口处，一个新兴的破坏性工业部门需要相关的实验室生物系统，用于在早期开发阶段筛选和选择药物，再加上减少，细化，替代体内试验。转化障碍和行业需求：组织工程/再生医学行业需要增加训练有素的多学科人员的数量，以转化基础研究，提供新产品开发，提高制造和加工能力，开发临床前测试方法，并制定标准，并在动态监管环境中工作。来自再生医学N8行业研讨会的证据。学术需求：一个迅速崛起的具有国际竞争力的跨学科领域，需要新鲜血液-